Spring has Sprung!
I, like many others will be looking forward to the upcoming ACTS meeting in Chicago this month for the first 3D meeting in two years. Hopefully BA.2 will remain muted, at least in the Chicago area which is currently rated ‘low’ by the CDC’s community level measure. Closer to home in the DC region, there has been some other activity over the past several weeks that has engendered some other community transmission angst. Specifically, Congress delivered a full year budget for FY22 which we are now more than halfway through. While NCATS overall received a $26.9M increase (3.14%), CTSAs received a $19.8M increase (3.37%); the latter being in line with the rest of NIH before adding in IC specific earmarks.
By: Michael Kurilla, M.D., Ph.D., NCATS Director of the Division of Clinical Innovation
NEWS
Spotlight Story
Empowering Researchers Through Coaching: UMN KL2 Scholar Leans into Community-Engaged Research
Coaching has been a powerful force for catalyzing the success of early-career researchers at the University of Minnesota. Take former KL2 scholar Kate Diaz Vickery, MD, MSc, as an example. The clinician-investigator credits coaching with giving her the confidence and encouragement to lean into the community-engaged research she’s passionate about and explore outside-the-box approaches. This shone through last fall, when she participated alongside community members in a theater workshop and performance with zAmya Theater that shares her research on living with type 2 diabetes while homeless.
N3C’s New Public Health Browser Makes COVID-19 Snapshot Data Accessible to All
The National COVID Cohort Collaborative recently launched the Public Health Browser, which provides snapshots of high-value COVID-19 data for policy makers, investigators, and entrepreneurs to facilitate further research questions for better health outcomes.
Last chance to register for the upcoming Spring CTSA Program Group Meetings
Registration closes at the end of the day today so check out the agendas and register now!
Learn More
Vanderbilt CTSA Receives Third Renewal, Addresses Health Disparities
Vanderbilt University Medical Center has competed successfully for a third five-year renewal of its Clinical and Translational Science (UL1) Award by the National Center for Advancing Translational Sciences. Initially funded in2007, the renewal will provide more than $73 million for another five years to support the Vanderbilt Institute for Clinical and Translational Research (VICTR) and its efforts to speed the translation of scientific discoveries from laboratory bench to the patient’s bedside, with a special emphasis on reducing health disparities.
Submitted byVanderbilt Institute for Clinical and Translational Research.
Accelerating Translation through Training in Innovation and Entrepreneurship
In the recent Journal of Clinical and Translational Sciences (JCTS) thematic issue on Entrepreneurship and Innovation, institutions showcase their experience, approaches, and findings in the area of innovation and academic entrepreneurship. Translating innovations into improved human health reflects NCATS’ mission and the goals of the CTSA Program. Through the CTSA Program, hubs work tirelessly to turn local discoveries into widespread innovations to accelerate the pace of clinical and translational science. Making sure these innovative approaches are leveraged is part of academic entrepreneurship: as Dr. Robert Kimberly pointed out in this issue of JCTS, “there are now vibrant bottom-up efforts at many such academic health centers to grow an academic culture that values entrepreneurship and innovation.”
Submitted by University of Alabama at Birmingham and NCATS.
FUNDING REMINDERS
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship.
NEW: FAQs.
Due Date: April 08, 2022
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Notice of Special Interest(NOSI): Recruitment Innovation Center (RIC) Topic Area for Limited Competition: Clinical and Translational Science Award Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Notice of Special Interest (NOSI) Trial Innovation Center (TIC) Topic Area for Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Notice of Technical Assistance Webinar for June 21, 2022 submission date of Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
Notice of Change in Eligibility to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Notice of Change in Award Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Notice of Change in Funding Opportunity Description and Application and Submission Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Notice of Special Interest: NIDCR Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Dental, Oral, and Craniofacial Clinical and Translational Research Career Development
CONSORTIUM CORNER
Highlights from the Trial Innovation Network- New RIC Publication in Press
The Recruitment Innovation Center (RIC) has recently published a new manuscript providing recruitment and retention guidance for researchers as they are designing studies. The RIC consults with CTSA hubs on strategies to increase clinical trial enrollment by developing, testing, and sharing innovations to enhance participant recruitment and retention. After 220 consultations with investigators, the RIC has compiled four primary recommendations for addressing common pitfalls in recruitment and retention- “
What we wish every investigator knew: Top 4 recruitment and retention recommendations from the Recruitment Innovation Center”.
The
Trial Innovation Network, comprised of all CTSA Hubs, Trial Innovation Centers, and the RIC, was established to transform multi-site research by reducing delays in trial start-up, speeding recruitment, and harmonizing processes across the CTSA Hubs, ultimately increasing quality and efficiency. To that end, the network has established resources, toolkits and best practices to assist research teams with study design, study start up, study implementation, study closeout and recruitment and retention. A list of TIN publications is
here. The
TIN websiteprovides instructions for research teams who wish to partner with the TIN, a resource toolkit, and an archived set of webinars highlighting topics important for multi-center research studies. For questions, please contact
info@trialinnovationnetwork.org.
View all posts